Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.59 GBX | +3.46% | +3.76% | -2.71% |
Feb. 23 | Plant Health eyes Mexico Saori launch; NARF wins deal | AN |
Feb. 22 | Plant Health Care Secures Approval for Fungicide Peptide Product in Mexico | MT |
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.62 for the current period. Therefore, the company is undervalued.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.71% | 15.5M | - | ||
+4.67% | 15.62B | B+ | ||
-11.29% | 15.57B | D+ | ||
-9.15% | 10.44B | B+ | ||
-5.07% | 8.06B | A- | ||
-.--% | 7.28B | - | C- | |
-5.72% | 6.33B | - | ||
-14.11% | 3.8B | B- | ||
-26.37% | 2.46B | D | ||
-6.36% | 1.94B | - | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock
- Equities
- Stock Plant Health Care plc - London S.E.
- Ratings Plant Health Care plc